Your browser doesn't support javascript.
loading
Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study.
Price, David B; Voorham, Jaco; Brusselle, Guy; Clemens, Andreas; Kostikas, Konstantinos; Stephens, Jeffrey W; Park, Hye Yun; Roche, Nicolas; Fogel, Robert.
Afiliação
  • Price DB; Observational and Pragmatic Research Institute, Singapore, Singapore. dprice@opri.sg.
  • Voorham J; Academic Primary Care, University of Aberdeen, Aberdeen, UK. dprice@opri.sg.
  • Brusselle G; Observational and Pragmatic Research Institute, Singapore, Singapore.
  • Clemens A; Ghent University Hospital, Ghent, Belgium, and Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Kostikas K; Novartis Pharma AG, Basel, Switzerland.
  • Stephens JW; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Park HY; Novartis Pharma AG, Basel, Switzerland.
  • Roche N; Respiratory Medicine Department, University of Ioannina, Ioannin, Greece.
  • Fogel R; Swansea University Medical School, Swansea University, Swansea, UK.
NPJ Prim Care Respir Med ; 29(1): 38, 2019 10 28.
Article em En | MEDLINE | ID: mdl-31659161

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose / Corticosteroides / Medição de Risco / Doença Pulmonar Obstrutiva Crônica / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose / Corticosteroides / Medição de Risco / Doença Pulmonar Obstrutiva Crônica / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2019 Tipo de documento: Article